Cartesian Therapeutics's total assets for Q4 2025 were $296.41M, a decrease of -20.46% from the previous quarter. RNAC total liabilities were $422.65M for the fiscal quarter, a 3.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.